E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes

Table 3

The association between E2F1 mRNA expression and clinicopathological characteristics in gastric cancer (^∗).

Clinicopathological characteristics	Number of patients	E2F1 (−△△CT value)	value
Gender			0.3910
Male	51	1.460 + 0.2977
Female	11	0.8645 + 0.5380
Age (Years old)			0.9699
<63	26	1.366 + 0.3811
≥63	36	1.346 + 0.3637
Differentiation			0.0368^∗
Well, moderate	16	0.4294 + 0.3463
Poor	46	1.676 + 0.3214
Lymph node metastasis			0.1303
0	19	0.7547 + 0.3995
≥1	43	1.619 + 0.3300
Tumor size			0.0125^∗
<4	25	0.5664 + 0.2620
≥4	37	1.887 + 0.3815
T Stage			0.0241^∗
T1-2	18	0.4361 + 0.3125
T3-4	44	1.730 + 0.3330
Ki67 positive rate (%)			0.0913
≤30	24	0.7958 + 0.4324
>30	38	1.707 + 0.3218